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 Alterations in energy metabolism constitute one of the large changes that 
cells undergo in conversion to the cancerous state. Ketone bodies represent a sub-
stantially under-investigated energy source and ketogenic diets show promise for 
correction or prevention of the altered metabolic state of cancers. The original ob-
servations of Otto Warburg on the energetics of the tumor provide a conceptual 
framework for current research. 
  Warburg found that cancer cells produced a higher ratio of lactic acid to 
CO2 than normal cells. His interpretation was that cancer cells had an increased 
reliance on glycolysis (anaerobic metabolism) as opposed to aerobic respiration and 
he thought that this was a characteristic of all cancer cells.  While it turned out not 
to be that simple, many if not most tumors do show a Warburg effect. Much cancer 
research might be described as a hunt for the points of disruption in the aerobic 
and/or anaerobic metabolism – or, most likely, the connection between them. Here 
we review broad outlines of energetic mechanisms with an eye on the Warburg 
effect and how ketone bodies might make a difference.   
 Start from the beginning. The black box of life takes food (glucose for sim-
plicity) and oxygen as inputs and puts out CO2 and water. The net effect is to pro-
duce energy in the form of ATP.  
 A look inside the black box shows individual processes. Glycolysis converts 
glucose to two molecules of the three-carbon compound pyruvate. This is the 
branch point. Pyruvate has many fates, providing the major substrate for aerobic 
energy metabolism as well as providing the starting point for gluconeogenesis and, 
in its conversion to lactate, an indicator of dependence on anerobic metabolism. 
 Pyruvate can be oxidized to acetyl-CoA, the derivative of acetic acid that is 
the substrate for oxidative metabolism in the tricarboxylic acid cycle (TCA cycle; 
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Krebs cycle).  In cells that don’t carry out respiration (red blood cells, rapidly ex-
ercising muscle) or under conditions of reduced oxygen (hypoxic environment of 
many cancer cells), pyruvate can be reduced to lactate. 
 
  
 Acetyl-CoA is also supplied by fatty acids. Under conditions of low total 
caloric or low carbohydrate input, the liver converts acetyl CoA to the ketone bod-
ies β-hydroxy butyrate and acetoacetate. The ketone bodies are transported to pe-
ripheral tissues where they are, in effect, converted back to acetyl-CoA; the func-
tion of the ketone bodies is to transport acetyl-CoA from liver to the tissues. 
 In the TCA cycle Acetyl-CoA is oxidized to CO2 by the oxidative coenzyme 
NAD+. The product NADH is oxidized in the electron transport chain (ETC) where 
a “bucket-brigade” of proteins in the mitochondrial membrane allow transfer of 
reducing power sequentially, ultimately to molecular oxygen (where the H2O 
comes from in the black box). The high-energy state that is generated is due to a 
membrane H+ gradient; that is, the effect of the oxidation moves protons to the 
outside of the inner mitochondrial membrane. Dissipation of the gradient through 
the F1FO particle in the mitochondrial membrane generates ATP. The overall pro-
cess is called oxidative phosphorylation (OxPhos).  
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 Pyruvate dehydrogenase (PDH), the enzyme that converts pyruvate to ace-
tyl-CoA, is the big traffic cop. Acetyl-CoA, the product of the reaction, feeds back 
to turn off its own production. This ensures that if acetyl-CoA is already high (from 
fat or ketone bodies), any pyruvate (from amino acids, for example) will be chan-
neled into gluconeogenesis or other processes.  
 Several kinds of metabolic inhibitors aid in the characterization of mecha-
nism. OxPhos inhibitors, such as oligomycin, knock out ATP production by pre-
venting utilization of the gradient. (The ‘O’ in F1FO stands for oligo). This stops the 
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whole oxidative process. Any remaining ATP generated must come from glycoly-
sis. Uncouplers (e.g. FCCP), as the name implies, separate the oxidation of sub-
strate in the ETC from ATP production. The mechanism is to destroy the high-
energy state of the membrane by allowing unproductive passage of H+ back into 
the mitochondrion. Oxidation of acetyl CoA will continue — actually increases 
because, not coupled to anything, it will run free — but no ATP can be made. Glu-
cose uptake can be blocked by inhibitors such as the drug cytochalasin B or analogs 
such as 2-deoxyglucose.  
 We have previously shown that one of the ketone bodies, acetoacetate, will 
inhibit both growth and ATP productionin several cancer lines [1]. A normal fibro-
blast line served as control and was not affected by acetoacetate. We have more 
recently shown that glucose uptake in several lines is inhibited as much by aceto-
acetate as by cytochalasin. Our preliminary results with inhibitors showed a reduc-
tion in aerobic metabolism — lower oxygen uptake and smaller inhibition when 
treated with oligomycin but, at the same time, we observed a lower glycolytic effect 
— smaller lactic acid and impaired ability to compensate for inhibition of respira-
tion with oligomycin. Whether the latter effect might indicate a way to target the 
oxidative glycolysis, as it is called, or, generally, whether the effects represent mul-
tiple responses or arise from a single reaction with acetoacetate is the target of fu-
ture research. 
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